Furachel en es it fr

Categoria

Furachel Nombres de marca, Furachel Analogos

Furachel Marca los nombres de mezcla

  • No information avaliable
  • Furachel Formula quimica

    C8H6N4O5

    Furachel RX enlace

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Furachel FDA hoja

    Furachel MSDS (hoja de seguridad de materiales)

    Furachel MSDS

    Furachel Sintesis de referencia

    No hay información disponible

    Furachel Peso molecular

    238.157 g/mol

    Furachel Punto de fusion

    263 oC

    Furachel H2O Solubilidad

    79.5 mg / L

    Furachel Estado

    Solid

    Furachel LogP

    -0.04

    Furachel Formas de dosificacion

    Tableta

    Furachel Indicacion

    Para el tratamiento de la infección del tracto urinario

    Furachel Farmacologia

    Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.

    Furachel Absorcion

    No hay información disponible

    Furachel Toxicidad

    No hay información disponible

    Furachel Informacion de Pacientes

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Furachel Organismos afectados

    Gram negativos y algunas bacterias gram positivas